CeeTox

Our Company

Overview

CeeTox, Inc. was founded in July of 2003 as a Contract Research Organization focused on in vitro toxicity screening of potential drug candidates and chemicals. CeeTox resides in 4,200-square-feet of state-of-the-art laboratory space in the Southwest Michigan Innovation Center (SMIC), a $13 million facility that serves as an incubator for new biotech companies in the Southwest Michigan area.

The scientists at CeeTox have a collective experience of more than 100 years in areas of cell culture, biochemistry, and toxicology. The team has analyzed more than 4,000 new chemical entities and has repeatedly demonstrated the value of early in vitro toxicity data in the drug discovery process.

Key Personnel

CeeTox CEO - James M. McKim, PhD, DABT

James M. McKim, Ph.D.
President and CEO

Vice President of Operations - Beth Allen

Beth Allen, Ph.D.
Chief Operations Officer

Vice President of Sales

Michael Watson
VP of Sales

CeeTox VP and Director of Science - Paul Wilga, MS

Paul Wilga
VP and Director of Science

CeeTox Controller - Susan Crookston

Susan Crookston
Controller

CeeTox Technical Services Specialist - Karen L. Rutherford-Root

Karen L. Rutherford-Root
Laboratory Project Manager

CeeTox Sr. Research Scientist and Director of New Technologies - Jeff Pregenzer, MS

Jeff Pregenzer
Senior Research Scientist/
Director of New Technologies

CeeToc Laboratory Manager - Diane Petrella

Diane Petrella
Laboratory Manager